Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells
Multidrug resistance (MDR) is the leading cause of failure for breast cancer in the clinic. Thus far, polymer-lipid hybrid nanoparticles (PLN) loaded chemotherapeutic agents has been used to overcome MDR in breast cancer. In this study, we prepared psoralen polymer-lipid hybrid nanoparticles (PSO-PL...
Saved in:
Main Authors: | Qingqing Huang (Author), Tiange Cai (Author), Qianwen Li (Author), Yinghong Huang (Author), Qian Liu (Author), Bingyue Wang (Author), Xi Xia (Author), Qi Wang (Author), John C. C. Whitney (Author), Susan P. C. Cole (Author), Yu Cai (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effects of psoralen polymer lipid nanoparticles on doxorubicin - induced myocardial toxicity
by: Fansu Meng, et al.
Published: (2022) -
MCF-7 and its Multidrug Resistant Variant MCF-7/ADR Overcome TNF Cytotoxicity through Prevention of Reactive Oxygen Species Accumulation
by: Morteza Ghandadi, et al.
Published: (2019) -
Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway
by: Lin Yang, et al.
Published: (2020) -
A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells
by: Mohammed H. Abdelaziz, et al.
Published: (2023) -
A Review of the Pharmacological Properties of Psoralen
by: Yali Ren, et al.
Published: (2020)